1. Health Technology Entrepreneurship Commercialization Consultants Technology Development Contents 2 3 4 About Health TECC Health TECC’s Clients The Application Process Health TECC advises early-stage healthcare focused companies The Healthcare Consulting and Entrepreneurship Program (HCEP), now known as Health TECC, was established at Boston University in 1996. Health TECC’s mission is to support entrepreneurship in health care, focusing on businesses in the incubation and start-up phase. Health TECC specializes in pharmaceuticals, biotechnology, medical device, and other healthcare technology including health IT.

2.  The combination of business, engineering, scientific and medical expertise represented by the grad student members of the group is at the core of what allows the group to provide outstanding and timely help. Michael Koeris, Novophage CEO  History TECC was founded in 2011 when consultants from the HCEP became affiliated with the Office of Technology and Development (OTD) and merged with IPconnectED, a student group focused on intellectual property. Health TECC is now the exclusive student group affiliated with OTD in providing healthcare-focused consulting services. The Health TECC experience Health TECC members are pro-bono consultants specializing in pharmaceuticals, biotechnology, and medical device. Health TECC collaborates with entrepreneurs affiliated with the Office of Technology Development, the Photonics Center, BioSquare, the Fraunhofer USA Center, and the Entrepreneurial Management Institute. Members Health TECC members are an interdisciplinary group of graduate students composed of MBA, PhD, and medical students. This year, Health TECC aims to expand its membership to law students. Services: Market access Reimbursement strategy Health economics Opportunity assessment Regulatory considerations Intellectual property and patent law Health TECC2

3. Employers of Past and Current Health TECC Members: BearingPoint Biogen Biotronic Boston MedTech Advisors Bridgehead International Bristol- Myers Squibb’s biotechnology technical services division Campbell Alliance Cadence Capital Decision Resources Electronic Systems Center and Space and Missile Command Flagship Ventures Genzyme Johns Hopkins Institute for Cell Engineering Leerink Swann McKinsey The MITRE Corporation National Cancer Institute Novophage Palomar Medical Technologies PricewaterhouseCoopers PRTM Management Consultants Sentient Medical Systems Past Clients Novophage Novophage provides biological solutions for industrial biofilms and has recently received $5.75 million in funding. Michael Koeris, the CEO, who served as an HCEP consultant during his PhD candidacy at Boston University, requested HCEP’s consulting services. As advisors, HCEP: analyzed potential regulatory pathways for approval of a novel phage-based antimicrobial; Health TECC3 appraised the client of the regulatory environment; and identified potential collaborators for Novophage. Good Start Genetics Good Start Genetics provides the next generation in technology for genetic screening. HCEP contributions included: comparing capital financing options for large equipment purchases through financial modeling; identifying key opinion leaders; and formulating recommendations that suited the business and cash flow needs of the client. Entra Pharmaceuticals Entra Pharmaceuticals is a medical device company that focuses on innovative drug delivery technology. HCEP consultants: investigated four therapeutic areas and identified a market access strategy; and provided a competitive analysis of the medical device industry. Entra Pharmaceuticals implemented many of HCEP’s recommendations, including a strategy for new product development. Companion Diagnostics A client with a start-up specializing in companion diagnostics approached HealthTECC, who: conducted primary research with prominent pathologists and oncologists to facilitate market adoption; performed a thorough analysis of the regulatory pathway for medical diagnostics; developed economic models to compare potential business structures; and evaluated the advantages and disadvantages in bringing the product to market as a companion diagnostic. Medical Device A client who developed a product for the early detection of autism utilized HealthTECC to : conduct primary research to evaluate factors surrounding market adoption from customer and consumer perspectives; qualified the current reimbursement landscape; quantified the value-added, which was used for value-based pricing; and examined HIPAA issues the client would likely encounter due to the use of HIT. Areas of Expertise: Anti-Infectives Child Development Companion Diagnostics Genetic Screening Neurology Oncology Personalized Medicine 

4. Health TECC will accept applications from: The School of Management The College of Engineering The Law School Boston Medical Center What To Expect Confirmation upon receipt of application Application deadline: Wednesday October 16, 2013 Notification of interview selection by: Sunday October 20, 2013 Interview date: Tuesday October 22, 2013 New consultants announced by: Sunday October 27, 2013 New member introduction at first general meeting: Wednesday October 30, 2013 Health TECC4 Managing Directors Cory Peterson, MBA Candidate Salwa Masud, MS Candidate, BME http://www.bu.edu/otd/education/tecc- student-consultants/ Facebook: Technology Entrepreneurship and Commercialization Consultants (TECC) Email inquiries: HealthTECC.BU@gmail.com